SCHEMBL4434026

SCHEMBL4434026

Oc1cccc(-c2ccc3cccc(O)c3n2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 2/20 0.56
▸ MAP4K4 O95819 1/20 0.52
▸ KMT2A Q03164 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ HSD17B1 P14061 7/20 0.50
▸ HSD17B2 P37059 7/20 0.50
▸ ESR1 P03372 3/20 0.49
▸ ESR2 Q92731 3/20 0.49
▸ METAP2 P50579 1/20 0.49
▸ PLAU P00749 1/20 0.49
▸ NCF1 P14598 1/20 0.49
▸ HSD17B14 Q9BPX1 1/20 0.48
▸ CYP1A2 P05177 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ ALOX12 P18054 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17174075 0.87 MAP4K4 (0.56) MAP4K4HSD17B1HSD17B2ESR1ESR2
SCHEMBL17174076 0.84 MAP4K4 (0.54) MAP4K4HSD17B1HSD17B2ESR1ESR2
SCHEMBL564494 0.84 PARP1 (0.58) PDE4DKMT2AMEN1NPC1ESR1
SCHEMBL29729655 0.84 PARP1 (0.58) PDE4DKMT2AMEN1NPC1ESR1
SCHEMBL29040612 0.82 PARP1 (0.57) PDE4DKMT2AMEN1NPC1ESR1
SCHEMBL29040616 0.82 PARP1 (0.57) PDE4DKMT2AMEN1NPC1ESR1
Lithium SCHEMBL17924084 0.82 PARP1 (0.57) PDE4DKMT2AMEN1NPC1ESR1
SCHEMBL6431677 0.82 PARP1 (0.57) PDE4DKMT2AMEN1NPC1ESR1
SCHEMBL30457867 0.82 PARP1 (0.57) PDE4DKMT2AMEN1NPC1ESR1
SCHEMBL16586107 0.82 PARP1 (0.57) PDE4DKMT2AMEN1NPC1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2131826-A2 17BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-DEPENDENT DISEASES Universität des Saarlandes (DE) 2009-12-16 — — EP claimed
WO-2008116920-A2 17BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-DEPENDENT DISEASES Universität des Saarlandes (DE) 2008-10-02 — — WO claimed
EP-2131826-A2 17BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-DEPENDENT DISEASES Universität des Saarlandes (DE) 2009-12-16 — — EP disclosed
WO-2008116920-A2 17BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-DEPENDENT DISEASES Universität des Saarlandes (DE) 2008-10-02 — — WO disclosed
Send feedback